Agopyan Nadia 4
4 · Marker Therapeutics, Inc. · Filed Mar 12, 2020
Insider Transaction Report
Form 4
Agopyan Nadia
VP, Regulatory Affairs
Transactions
- Award
Employee Stock Option (Right to Buy)
2020-03-10+7,300→ 7,300 totalExercise: $2.12Exp: 2030-03-10→ Common Stock (7,300 underlying) - Award
Employee Stock Option (Right to Buy)
2020-03-10+32,700→ 32,700 totalExercise: $2.12Exp: 2030-03-10→ Common Stock (32,700 underlying)
Footnotes (2)
- [F1]Represents a bonus for 2019 performance granted under the Company's 2014 Omnibus Stock Ownership Plan. This option vests in equal monthly installments over a four year period commencing on April 10, 2020 subject to the continued service by the Reporting Person to the Issuer as of the applicable vesting date.
- [F2]This option vests in equal monthly installments over a four year period commencing on April 10, 2020 subject to the continued service by the Reporting Person to the Issuer as of the applicable vesting date.